D-Index & Metrics Best Publications
Microbiology
France
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 69 Citations 24,005 384 World Ranking 1242 National Ranking 71

Research.com Recognitions

Awards & Achievements

2023 - Research.com Microbiology in France Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Gene
  • Internal medicine

His primary scientific interests are in Virology, Mimivirus, Giant Virus, Mimiviridae and Marseilleviridae. Virus is the focus of his Virology research. Philippe Colson has included themes like Hydroxychloroquine, Coxiella burnetii, Doxycycline and Azithromycin in his Virus study.

Philippe Colson works mostly in the field of Mimivirus, limiting it down to concerns involving Acanthamoeba and, occasionally, Phylogenetics and Lineage. His studies examine the connections between Giant Virus and genetics, as well as such issues in Asfarviridae, with regards to Metagenomics. The Marseilleviridae study combines topics in areas such as Marseillevirus and Mamavirus.

His most cited work include:

  • Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. (2594 citations)
  • New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? (491 citations)
  • Pig liver sausage as a source of hepatitis E virus transmission to humans. (477 citations)

What are the main themes of his work throughout his whole career to date?

Philippe Colson focuses on Virology, Giant Virus, Virus, Genetics and Genome. His Virology research is multidisciplinary, relying on both Severe acute respiratory syndrome coronavirus 2, Immunology and Genotype, Hepatitis E virus. His work carried out in the field of Hepatitis E virus brings together such families of science as Epidemiology, Hepatitis E, Zoonosis and Hepatitis.

His study looks at the intersection of Giant Virus and topics like Mimivirus with Acanthamoeba and Evolutionary biology. Philippe Colson is interested in Viral load, which is a field of Virus. His research brings together the fields of Hydroxychloroquine and Viral load.

He most often published in these fields:

  • Virology (54.27%)
  • Giant Virus (20.11%)
  • Virus (17.63%)

What were the highlights of his more recent work (between 2019-2021)?

  • Virology (54.27%)
  • Severe acute respiratory syndrome coronavirus 2 (8.26%)
  • Coronavirus disease 2019 (7.16%)

In recent papers he was focusing on the following fields of study:

His main research concerns Virology, Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, Genome and Internal medicine. His biological study spans a wide range of topics, including Reverse transcription polymerase chain reaction, Complementary DNA, DNA sequencing, Peripheral blood and Coronavirus. His Genome research includes elements of Virus, Clade and Genotype.

His Internal medicine study incorporates themes from Viral load and Azithromycin. His Azithromycin study combines topics from a wide range of disciplines, such as Young adult, Clinical trial and Viral shedding. His Hydroxychloroquine research includes themes of Observational study and Randomized controlled trial.

Between 2019 and 2021, his most popular works were:

  • Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. (2594 citations)
  • New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? (491 citations)
  • Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19 (465 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • Gene
  • Internal medicine

Philippe Colson spends much of his time researching Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Hydroxychloroquine, Internal medicine and Virology. His Hydroxychloroquine research incorporates elements of Observational study, Randomized controlled trial, Virus, Pandemic and Azithromycin. His Virus study combines topics in areas such as Genome project and Genome.

His research integrates issues of Young adult and Clinical trial in his study of Azithromycin. His Internal medicine research integrates issues from Point of care, Point-of-care testing and Viral load. His study in Virology is interdisciplinary in nature, drawing from both DNA sequencing, Coronavirus and Pneumonia.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Philippe Gautret;Jean Christophe Lagier;Philippe Parola;Van Thuan Hoang.
International Journal of Antimicrobial Agents (2020)

5474 Citations

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Christian A. Devaux;Christian A. Devaux;Jean Marc Rolain;Philippe Colson;Didier Raoult.
International Journal of Antimicrobial Agents (2020)

1157 Citations

Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19

Philippe Colson;Jean-Marc Rolain;Jean-Christophe Lagier;Philippe Brouqui.
International Journal of Antimicrobial Agents (2020)

996 Citations

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.

Philippe Gautret;Jean Christophe Lagier;Philippe Parola;Van Thuan Hoang.
Travel Medicine and Infectious Disease (2020)

796 Citations

Pig liver sausage as a source of hepatitis E virus transmission to humans.

Philippe Colson;Patrick Borentain;Benjamin Queyriaux;Benjamin Queyriaux;Mamadou Kaba.
The Journal of Infectious Diseases (2010)

723 Citations

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.

Bernard La Scola;Marion Le Bideau;Julien Andreani;Van Thuan Hoang.
European Journal of Clinical Microbiology & Infectious Diseases (2020)

713 Citations

rpoB-Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing Mycobacteria

Toïdi Adékambi;Philippe Colson;Michel Drancourt.
Journal of Clinical Microbiology (2003)

539 Citations

Chloroquine for the 2019 novel coronavirus SARS-CoV-2.

Philippe Colson;Jean-Marc Rolain;Didier Raoult.
International Journal of Antimicrobial Agents (2020)

498 Citations

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.

Matthieu Million;Jean Christophe Lagier;Philippe Gautret;Philippe Colson.
Travel Medicine and Infectious Disease (2020)

471 Citations

Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century.

Jean Marc Rolain;Philippe Colson;Didier Raoult.
International Journal of Antimicrobial Agents (2007)

419 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Philippe Colson

Didier Raoult

Didier Raoult

Aix-Marseille University

Publications: 401

Pierre-Edouard Fournier

Pierre-Edouard Fournier

Aix-Marseille University

Publications: 127

Jacques Izopet

Jacques Izopet

Federal University of Toulouse Midi-Pyrénées

Publications: 118

Bernard La Scola

Bernard La Scola

Aix-Marseille University

Publications: 95

Nassim Kamar

Nassim Kamar

Paul Sabatier University

Publications: 80

Florence Abravanel

Florence Abravanel

Grenoble Alpes University

Publications: 59

Jean-Christophe Lagier

Jean-Christophe Lagier

Aix-Marseille University

Publications: 55

Jean-Marc Rolain

Jean-Marc Rolain

Aix-Marseille University

Publications: 49

Michel Drancourt

Michel Drancourt

Aix-Marseille University

Publications: 48

Eugene V. Koonin

Eugene V. Koonin

National Institutes of Health

Publications: 39

Jean-Michel Claverie

Jean-Michel Claverie

Aix-Marseille University

Publications: 38

Lionel Rostaing

Lionel Rostaing

Grenoble Alpes University

Publications: 35

Hiroaki Okamoto

Hiroaki Okamoto

Jichi Medical University

Publications: 35

Enrico Tortoli

Enrico Tortoli

Vita-Salute San Raffaele University

Publications: 27

Gilbert Greub

Gilbert Greub

University of Lausanne

Publications: 25

Xiang-Jin Meng

Xiang-Jin Meng

Virginia Tech

Publications: 24

Trending Scientists

Amir H. Gandomi

Amir H. Gandomi

University of Technology Sydney

Bernhard Raaf

Bernhard Raaf

Intel (United States)

Ken Hosoya

Ken Hosoya

Kyoto Prefectural University

Carlos González

Carlos González

Technical University of Madrid

Mark A. McPeek

Mark A. McPeek

Dartmouth College

Makoto Kanzaki

Makoto Kanzaki

Tohoku University

Li-Hua Xu

Li-Hua Xu

Yunnan University

Robert J. Baker

Robert J. Baker

Texas Tech University

Dirk P. Dittmer

Dirk P. Dittmer

University of North Carolina at Chapel Hill

Patrick D. Nunn

Patrick D. Nunn

University of the Sunshine Coast

Paulin Coulibaly

Paulin Coulibaly

McMaster University

Rochelle F. Hanson

Rochelle F. Hanson

Medical University of South Carolina

Prediman K. Shah

Prediman K. Shah

Cedars-Sinai Medical Center

Gary L. Darmstadt

Gary L. Darmstadt

Stanford University

Michael Forsting

Michael Forsting

University of Duisburg-Essen

Renate B. Schnabel

Renate B. Schnabel

Universität Hamburg

Something went wrong. Please try again later.